Paula Soteropoulos, Director at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 599 shares at $80.11 ($48K) on 2026-03-31, disclosed to the SEC on 2026-04-01.
Scheduled sale ($48k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| QURE | SELL | 2024-06-17 | $11K | — | Filing → |
| QURE | SELL | 2023-06-20 | $43K | — | Filing → |
| QURE | SELL | 2023-03-01 | $8K | — | Filing → |